- Home
- MIST vs GUTS Comparison
MIST vs GUTS Comparison
Compare MIST & GUTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- GUTS
- Stock Information
- Founded
- MIST 2003
- GUTS 2010
- Country
- MIST Canada
- GUTS United States
- Employees
- MIST N/A
- GUTS N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- GUTS
- Sector
- MIST Health Care
- GUTS
- Exchange
- MIST Nasdaq
- GUTS NYSE
- Market Cap
- MIST 53.9M
- GUTS 58.8M
- IPO Year
- MIST N/A
- GUTS 2024
- Fundamental
- Price
- MIST $1.11
- GUTS $1.62
- Analyst Decision
- MIST Strong Buy
- GUTS Buy
- Analyst Count
- MIST 2
- GUTS 1
- Target Price
- MIST $9.50
- GUTS $10.00
- AVG Volume (30 Days)
- MIST 1.6M
- GUTS 273.3K
- Earning Date
- MIST 05-20-2025
- GUTS 05-13-2025
- Dividend Yield
- MIST N/A
- GUTS N/A
- EPS Growth
- MIST N/A
- GUTS N/A
- EPS
- MIST N/A
- GUTS N/A
- Revenue
- MIST N/A
- GUTS $93,000.00
- Revenue This Year
- MIST N/A
- GUTS N/A
- Revenue Next Year
- MIST N/A
- GUTS N/A
- P/E Ratio
- MIST N/A
- GUTS N/A
- Revenue Growth
- MIST N/A
- GUTS N/A
- 52 Week Low
- MIST $0.63
- GUTS $0.87
- 52 Week High
- MIST $2.75
- GUTS $7.89
- Technical
- Relative Strength Index (RSI)
- MIST 43.96
- GUTS 64.21
- Support Level
- MIST $1.28
- GUTS $1.47
- Resistance Level
- MIST $1.32
- GUTS $1.80
- Average True Range (ATR)
- MIST 0.12
- GUTS 0.14
- MACD
- MIST 0.02
- GUTS 0.04
- Stochastic Oscillator
- MIST 27.39
- GUTS 70.49
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About GUTS FRACTYL HEALTH INC
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.